Cox Enterprises invested in digital media company Axios at a $430m valuation while Bristol Myers Squibb helped enzyme drug developer Nitrase Therapeutics boost its series A round to $45m.
Funding
Media and communications group Cox Enterprises has provided an undisclosed amount of series D funding for US-headquartered digital media company Axios at a $430m valuation, the latter reported reported yesterday. Axios had raised $10m from media group NBC Universal, Lerer Hippeau, Greycroft Partners, Emerson Collective and various angel investors as of its January 2017 launch, adding $20m from Greycroft, Lerer Hippeau, WndrCo, E.ventures and Greg Penner 10 months later.
US-based enzyme therapeutics developer Nitrome Biosciences rebranded to…
